Theresa M. Heggie's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 27,181 Automatic Stock Option Grant done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,181 | 27,181 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 12,500 | 65,352 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 49,933 | 49,933 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 6,820 | 59,550 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 12 Jun 2024 | 6,698 | 52,852 (0%) | 0% | 6.1 | 40,925 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 6.46 per share. | 31 May 2024 | 870 | 52,730 (0%) | 0% | 6.5 | 5,620 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 5.63 per share. | 29 Feb 2024 | 999 | 51,860 (0%) | 0% | 5.6 | 5,624 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 39,072 | 39,072 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 16,745 | 49,114 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 8.27 per share. | 31 May 2023 | 680 | 32,369 (0%) | 0% | 8.3 | 5,624 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 8.85 per share. | 28 Feb 2023 | 635 | 31,689 (0%) | 0% | 8.9 | 5,620 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 13.36 per share. | 30 Nov 2022 | 421 | 31,054 (0%) | 0% | 13.4 | 5,625 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 13.90 per share. | 31 Aug 2022 | 404 | 30,633 (0%) | 0% | 13.9 | 5,616 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 30,022 | 30,022 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 12,866 | 30,229 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 9.31 per share. | 31 May 2022 | 1,138 | 17,363 (0%) | 0% | 9.3 | 10,595 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 16.61 per share. | 28 Feb 2022 | 602 | 16,225 (0%) | 0% | 16.6 | 9,999 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 12.06 per share. | 30 Nov 2021 | 829 | 15,623 (0%) | 0% | 12.1 | 9,998 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 15.92 per share. | 31 Aug 2021 | 628 | 14,794 (0%) | 0% | 15.9 | 9,998 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 15.77 per share. | 28 May 2021 | 317 | 14,166 (0%) | 0% | 15.8 | 4,999 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 40,000 | 40,000 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc. | Theresa M. Heggie | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 26 Feb 2021 | 463 | 13,849 (0%) | 0% | 10.8 | 4,991 | Common Stock |